MHC haplotype-dependent regulation of MOG-induced EAE in rats.

Experimental autoimmune encephalomyelitis (EAE) induced in the rat by active immunization with myelin-oligodendrocyte-glycoprotein (MOG) is mediated by synergy between MOG-specific T cells and demyelinating MOG-specific antibody responses. The resulting disease is chronic and displays demyelinating central nervous system (CNS) pathology that closely resembles multiple sclerosis. We analyzed major histocompatibility complex (MHC) haplotype influences on this disease. The MHC haplotype does not exert an all-or-none effect on disease susceptibility. Rather, it determines the degree of disease susceptibility, recruitment of MOG-specific immunocompetent cells, clinical course, and CNS pathology in a hierarchical and allele-specific manner. Major haplotype-specific effects on MOG-EAE map to the MHC class II gene region, but this effect is modified by other MHC genes. In addition, non-MHC genes directly influence both disease and T cell functions, such as the secretion of IFN-gamma. Thus, in MOG-EAE, allelic MHC class II effects are graded, strongly modified by other MHC genes, and overcome by effects of non-MHC genes and environment.

[1]  P. Santamaria,et al.  A Mechanism for the Major Histocompatibility Complex–linked Resistance to Autoimmunity , 1997, The Journal of experimental medicine.

[2]  R. Holmdahl,et al.  Identification and differentiation of transcribed major histocompatibility complex class II RT1Bα and RT1Bβ alleles from laboratory rats , 1997 .

[3]  H. Lassmann,et al.  Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[4]  G. Hämmerling,et al.  How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.

[5]  C. Benoist,et al.  Positive Selection of T Cells Induced by Viral Delivery of Neopeptides to the Thymus , 1997, Science.

[6]  R. Holmdahl,et al.  Identification and differentiation of transcribed major histocompatibility complex class II RT1B alpha and RT1B beta alleles from laboratory rats. , 1997, Transplantation proceedings.

[7]  M. Daly,et al.  Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Shevach,et al.  IL-12 unmasks latent autoimmune disease in resistant mice , 1996, The Journal of experimental medicine.

[9]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[10]  S. Cook,et al.  Handbook of Multiple Sclerosis , 1996 .

[11]  John A Todd,et al.  Genetic Analysis of Autoimmune Disease , 1996, Cell.

[12]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[13]  C. Melief,et al.  The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. , 1996, Immunity.

[14]  Tomas Olsson,et al.  Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant , 1995, Journal of Neuroimmunology.

[15]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[16]  H. Lassmann,et al.  The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat , 1995, Journal of Neuroimmunology.

[17]  R. Swanborg,et al.  A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. , 1995, Journal of immunology.

[18]  R. Holmdahl,et al.  Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis , 1995, Nature Genetics.

[19]  T. Johns,et al.  Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. , 1995, Journal of immunology.

[20]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.

[21]  A. Sette,et al.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.

[22]  O. Majdic,et al.  Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.

[23]  T. Olsson,et al.  Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles. , 1994, Journal of immunology.

[24]  H. Lassmann,et al.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.

[25]  H. Lassmann,et al.  Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. , 1994, Journal of immunology.

[26]  P. Ohashi,et al.  Positive and negative thymocyte selection induced by different concentrations of a single peptide. , 1994, Science.

[27]  C. Janeway,et al.  Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.

[28]  R B Smith,et al.  Insulin dependent diabetes mellitus. , 1992, The New Zealand medical journal.

[29]  J. Hillert,et al.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.

[30]  W. M. Adams,et al.  Genetic monitoring of inbred strains of rats : a manual on colony management, basic monitoring techniques, and genetic variants of the laboratory rat , 1990 .

[31]  A. Lanzavecchia,et al.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. , 1990, Annual review of immunology.

[32]  T. Olsson,et al.  Distribution of plasma cells secreting antibodies against nervous tissue antigens during experimental allergic encephalomyelitis enumerated by a nitrocellulose immunospot assay , 1989, Journal of the Neurological Sciences.

[33]  P. Marrack,et al.  Influence of the major histocompatibility complex on positive thymic selection of V beta 17a+ T cells. , 1989, Science.

[34]  P. Wettstein,et al.  Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. , 1988, Journal of immunology.

[35]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[36]  T. Tabira,et al.  Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats , 1986, Journal of Neuroimmunology.

[37]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[38]  P. Pereira,et al.  T Cell‐Dependent B Cell Activation , 1984, Immunological reviews.

[39]  C. Janeway,et al.  Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted , 1981, Nature.

[40]  S. Levine,et al.  Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. , 1975, Journal of immunology.